Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Gastrointestinal 1

Conditions

Glioblastoma 2Glioma 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Specimen Handling 629pembrolizumab 559Magnetic Resonance Spectroscopy 539Carboplatin 423Cyclophosphamide 371Cisplatin 371Biopsy 357Paclitaxel 304Nivolumab 301Gemcitabine 299Radiotherapy 270Bevacizumab 238Dexamethasone 207fludarabine 205Docetaxel 189durvalumab 178atezolizumab 176Oxaliplatin 172Fluorouracil 167venetoclax 164Rituximab 164Pemetrexed 162Radiation 159Doxorubicin 159Capecitabine 158Radiosurgery 147Etoposide 137Ipilimumab 134Leucovorin 133Lenalidomide 130

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Sitagliptin Phosphate × 90 days × Clear all
NCT07365592 2026-05-13

Neo-CD

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Recruiting
138 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07003542 2026-05-08

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Case Comprehensive Cancer Center

Phase 2 Recruiting
48 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT07541781 2026-04-21

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

University of Iowa

Phase 1 Not yet recruiting
45 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡